跳至主要内容
临床试验/JPRN-jRCT1022230003
JPRN-jRCT1022230003招募中Unknown

A multicenter prospective randomized study to evaluate the delivery timing safety and efficacy of AntiTachycardia Pacing - BIO|ATP

Ando Kenji0 个研究点目标入组 398 人开始时间: 2023年5月15日最近更新:

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
398

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 18age old 至 ot applicable(—)
性别
All

入选标准

  • Patient has an indication for ICD according to the JCS / JHRS 2021 Guideline Focused Update on Non-Pharmacotherapy of Cardiac Arrhythmias
  • - Patient is either planned for de novo ICD implantation or is already implanted with an investigational ICD for 10 days or less
  • - Patient can be treated with ATP therapy for both VT and VF zone
  • - Patient is willing and able to use the CardioMessenger and accepts the Home Monitoring concept
  • - Patient is willing to visit the hospital in accordance with physicians instruction
  • - Patient is able to understand the nature of the study and to provide written informed consent

排除标准

  • - Patient planned for implantation with or already implanted with CRT-D device
  • - A patient who is confirmed to have received ICD therapy
  • - A patient who is diagnosed as Idiopathic VF (e.g. Brugada syndrome, Long QT Syndrome, other IVF)
  • - Age < 18 years
  • - A patient who has impaired mental status
  • - Life expectancy less than 18 months
  • - Participation in another interventional clinical investigation
  • - Pregnant or breastfeeding

研究者

发起方
Ando Kenji

相似试验